跳至主要内容
临床试验/NCT03050489
NCT03050489已完成不适用

AMIRI-CABG: Assessment of Myocardial Ischemic-Reperfusion Injury During Off- and On- Pump CABG

St. Petersburg State Pavlov Medical University1 个研究点 分布在 1 个国家目标入组 336 人开始时间: 2015年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
336
试验地点
1
主要终点
Myeloperoxidase

研究概览

简要总结

Assessment of myocardial ischemic-reperfusion injury during off- and on- pump CABG.

详细描述

Assessment of myocardial ischemic-reperfusion injury during off- and on- pump CABG is monitored by intraoperative measurement of serum level of myeloperoxidase before sternotomy and after sternal closure.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
30 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ischemic heart disease

排除标准

  • valve disease
  • diabetes millitus

结局指标

主要结局

Myeloperoxidase

时间窗: Level of serum myeloperoxidase just after sternal closure

Level of serum myeloperoxidase just after sternal closure

次要结局

  • Cumulative Dose of Inotrope(Up to 30 days after procedure)
  • Systolic Function(Up to 14 days after surgical procedure)
  • Renal Dysfunction(Perioperative (before sternotomy and after sternal closure))
  • Length of Stay in Intensive Care Unit(During 30 days after procedure or more)
  • Diastolic Function(Up to 14 days after surgical procedure)
  • Atrial Fibrillation.(Up to 30 days after procedure)
  • Pulmonary Ventilation(During 30 days after procedure or more)
  • Low Cardiac Output Syndrome(Up to 30 days after surgical procedure)
  • Length of Stay in Hospital(During 30 days after procedure or more)
  • Days of Administration of Inotrope(During 30 days after procedure or more)
  • Number of Participants With Reoperation(Up to 30 days after procedure)

研究者

发起方
St. Petersburg State Pavlov Medical University
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验